Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2020 1
2021 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia.
Climent E, Marco-Benedí V, Benaiges D, Pintó X, Suárez-Tembra M, Plana N, Lafuente H, Ortega-Martínez de Victoria E, Brea-Hernando Á, Vila À, Civeira F, Pedro-Botet J. Climent E, et al. Among authors: vila a. Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1594-1603. doi: 10.1016/j.numecd.2021.01.014. Epub 2021 Jan 28. Nutr Metab Cardiovasc Dis. 2021. PMID: 33744038
Influence of triglyceride concentration in lipoprotein (a) as a function of dyslipidemia.
Marco-Benedí V, Cenarro A, Laclaustra M, Calmarza P, Bea AM, Vila À, Morillas-Ariño C, Puzo J, Mediavilla Garcia JD, Fernández Alamán AI, Suárez Tembra M, Civeira F. Marco-Benedí V, et al. Among authors: vila a. Clin Investig Arterioscler. 2024 Mar-Apr;36(2):71-77. doi: 10.1016/j.arteri.2023.11.005. Epub 2023 Dec 30. Clin Investig Arterioscler. 2024. PMID: 38161102 English, Spanish.
Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study.
Fernández-Cidón B, Candás-Estébanez B, Gil-Serret M, Amigó N, Corbella E, Rodríguez-Sánchez MÁ, Padró-Miquel A, Brotons C, Hernández-Mijares A, Calmarza P, Jarauta E, Brea AJ, Mauri M, Guijarro C, Vila À, Valdivielso P, Corbella X, Pintó X. Fernández-Cidón B, et al. Among authors: vila a. J Clin Med. 2021 Mar 29;10(7):1379. doi: 10.3390/jcm10071379. J Clin Med. 2021. PMID: 33805580 Free PMC article.
Familial hypercholesterolemia in a European Mediterranean population-Prevalence and clinical data from 2.5 million primary care patients.
Zamora A, Masana L, Comas-Cufí M, Vila À, Plana N, García-Gil M, Alves-Cabratosa L, Marrugat J, Roman I, Ramos R; XULA and ISV-Girona groups. Zamora A, et al. Among authors: vila a. J Clin Lipidol. 2017 Jul-Aug;11(4):1013-1022. doi: 10.1016/j.jacl.2017.05.012. Epub 2017 Jun 3. J Clin Lipidol. 2017. PMID: 28826564 Free article.
Polygenic Markers in Patients Diagnosed of Autosomal Dominant Hypercholesterolemia in Catalonia: Distribution of Weighted LDL-c-Raising SNP Scores and Refinement of Variant Selection.
Martín-Campos JM, Ruiz-Nogales S, Ibarretxe D, Ortega E, Sánchez-Pujol E, Royuela-Juncadella M, Vila À, Guerrero C, Zamora A, Soler I Ferrer C, Arroyo JA, Carreras G, Martínez-Figueroa S, Roig R, Plana N, Blanco-Vaca F, Xarxa d'Unitats de Lípids I Arteriosclerosi Xula. Martín-Campos JM, et al. Among authors: vila a. Biomedicines. 2020 Sep 15;8(9):353. doi: 10.3390/biomedicines8090353. Biomedicines. 2020. PMID: 32942679 Free PMC article.
Causes of failure to achieve the low density lipoprotein cholesterol therapeutic target in patients with high and very high vascular risk controlled in Lipid and Vascular Risk Units. EROMOT study.
Morales C, Plana N, Arnau A, Matas L, Mauri M, Vila À, Vila L, Soler C, Montesinos J, Masana L, Pedro-Botet J; en nombre del grupo de Investigadores EROMOT-XULA. Morales C, et al. Among authors: vila a. Clin Investig Arterioscler. 2018 Jan-Feb;30(1):1-9. doi: 10.1016/j.arteri.2017.07.003. Epub 2017 Sep 12. Clin Investig Arterioscler. 2018. PMID: 28916128 English, Spanish.